Recombinant Proteins Market Report

Global and Region Recombinant Proteins Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：178
  • REPORT CODE：GMM895516
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Recombinant Proteins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Proteinsmarket, defines the market attractiveness level of Recombinant Proteins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Proteins industry, describes the types of Recombinant Proteins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Proteins market and the development prospects and opportunities of Recombinant Proteins industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Proteins market in Chapter 13.

    By Player:

    • GigaGen Inc

    • Merck KGaA

    • GeneTex, Inc

    • Thermo Fisher Scientific Inc

    • Novo Nordisk AS

    • Bio-Rad Laboratories, Inc

    • Novavax, Inc

    • Biocon

    • Eli Lilly and Company

    • Novartis AG

    • Sanofi SA

    By Type:

    • Hormones

    • Growth Factors

    • Cytokines

    • Plasma Protein Factor

    • Recombinant Metabolic Enzymes

    • Immune Checkpoint Regulators

    • Others

    By End-User:

    • Biopharmaceutical Companies

    • Academic and Research Institutes

    • Contract Research Organizations

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Proteins Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Proteins Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Proteins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Proteins Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Proteins Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Proteins Consumption (2017-2022)

    • 7.2 United States Recombinant Proteins Consumption (2017-2022)

    • 7.3 Europe Recombinant Proteins Consumption (2017-2022)

    • 7.4 China Recombinant Proteins Consumption (2017-2022)

    • 7.5 Japan Recombinant Proteins Consumption (2017-2022)

    • 7.6 India Recombinant Proteins Consumption (2017-2022)

    • 7.7 South Korea Recombinant Proteins Consumption (2017-2022)

    8 Region and Country-wise Recombinant Proteins Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Proteins Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Proteins Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Proteins Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Proteins Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Proteins Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Proteins Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Proteins Consumption Forecast (2022-2028)

    9 Global Recombinant Proteins Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Proteins Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormones Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Growth Factors Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cytokines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Plasma Protein Factor Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Recombinant Metabolic Enzymes Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Immune Checkpoint Regulators Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Proteins Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Academic and Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Contract Research Organizations Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Proteins Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Proteins Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hormones Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Growth Factors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Plasma Protein Factor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Recombinant Metabolic Enzymes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Immune Checkpoint Regulators Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Proteins Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Academic and Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Contract Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Proteins Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Proteins Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Proteins Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Proteins Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Proteins Market Competitive Analysis

    • 14.1 GigaGen Inc

      • 14.1.1 GigaGen Inc Company Details

      • 14.1.2 GigaGen Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GigaGen Inc Recombinant Proteins Product and Service

    • 14.2 Merck KGaA

      • 14.2.1 Merck KGaA Company Details

      • 14.2.2 Merck KGaA Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck KGaA Recombinant Proteins Product and Service

    • 14.3 GeneTex, Inc

      • 14.3.1 GeneTex, Inc Company Details

      • 14.3.2 GeneTex, Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GeneTex, Inc Recombinant Proteins Product and Service

    • 14.4 Thermo Fisher Scientific Inc

      • 14.4.1 Thermo Fisher Scientific Inc Company Details

      • 14.4.2 Thermo Fisher Scientific Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Thermo Fisher Scientific Inc Recombinant Proteins Product and Service

    • 14.5 Novo Nordisk AS

      • 14.5.1 Novo Nordisk AS Company Details

      • 14.5.2 Novo Nordisk AS Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk AS Recombinant Proteins Product and Service

    • 14.6 Bio-Rad Laboratories, Inc

      • 14.6.1 Bio-Rad Laboratories, Inc Company Details

      • 14.6.2 Bio-Rad Laboratories, Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bio-Rad Laboratories, Inc Recombinant Proteins Product and Service

    • 14.7 Novavax, Inc

      • 14.7.1 Novavax, Inc Company Details

      • 14.7.2 Novavax, Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novavax, Inc Recombinant Proteins Product and Service

    • 14.8 Biocon

      • 14.8.1 Biocon Company Details

      • 14.8.2 Biocon Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biocon Recombinant Proteins Product and Service

    • 14.9 Eli Lilly and Company

      • 14.9.1 Eli Lilly and Company Company Details

      • 14.9.2 Eli Lilly and Company Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eli Lilly and Company Recombinant Proteins Product and Service

    • 14.10 Novartis AG

      • 14.10.1 Novartis AG Company Details

      • 14.10.2 Novartis AG Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis AG Recombinant Proteins Product and Service

    • 14.11 Sanofi SA

      • 14.11.1 Sanofi SA Company Details

      • 14.11.2 Sanofi SA Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Sanofi SA Recombinant Proteins Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Proteins

    • Figure Recombinant Proteins Picture

    • Table Global Recombinant Proteins Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Proteins Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Proteins Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Proteins Consumption by Country (2017-2022)

    • Figure United States Recombinant Proteins Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Proteins Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Proteins Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Proteins Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Proteins Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Proteins Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Proteins Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormones Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Cytokines Consumption and Growth Rate (2017-2022)

    • Figure Global Plasma Protein Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Metabolic Enzymes Consumption and Growth Rate (2017-2022)

    • Figure Global Immune Checkpoint Regulators Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Academic and Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Hormones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Plasma Protein Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Metabolic Enzymes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immune Checkpoint Regulators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic and Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Proteins Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Proteins Export by Region (Top 5 Countries) (2017-2028)

    • Table GigaGen Inc (Foundation Year, Company Profile and etc.)

    • Table GigaGen Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table GigaGen Inc Recombinant Proteins Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Recombinant Proteins Product and Service

    • Table GeneTex, Inc (Foundation Year, Company Profile and etc.)

    • Table GeneTex, Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneTex, Inc Recombinant Proteins Product and Service

    • Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Inc Recombinant Proteins Product and Service

    • Table Novo Nordisk AS (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk AS Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk AS Recombinant Proteins Product and Service

    • Table Bio-Rad Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Laboratories, Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories, Inc Recombinant Proteins Product and Service

    • Table Novavax, Inc (Foundation Year, Company Profile and etc.)

    • Table Novavax, Inc Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novavax, Inc Recombinant Proteins Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Recombinant Proteins Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Recombinant Proteins Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Recombinant Proteins Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Recombinant Proteins Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Recombinant Proteins Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US